Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome-Reference-Cited by-同舟云学术

Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome

Published:2010-07-29 Issue:23 Volume:116 Page:5420-5431
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

de Lima Marcos,Giralt Sergio,Thall Peter F.,de Padua Silva Leandro,Jones Roy B.,Komanduri Krishna,Braun Thomas M.,Nguyen Hoang Q.,Champlin Richard,Garcia-Manero Guillermo

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.25500/fullpdf

Reference36 articles.

1. Quantifying the survival benefit for allogeneic stem cell transplant in relapsed acute myeloid leukemia;Armistead;Biol Blood Marrow Transplant.,2009

2. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation;Thomas;Blood.,1977

3. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study;Fenaux;Lancet Oncol.,2009

4. Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies;Issa;Blood.,2004

5. Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias;de Lima;Cancer.,2003

Cited by 396 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing maintenance therapy in acute myeloid leukemia: where do we stand in the year 2024?;Expert Review of Hematology;2024-07-21

2. Azacitidine combined with interferon‐α for pre‐emptive treatment of AML/MDS after allogeneic peripheral blood stem cell transplantation: A prospective phase II study;British Journal of Haematology;2024-07-03

3. Post-Transplant Maintenance Therapy in Acute Myeloid Leukemia;Cancers;2024-05-26

4. WT1-guided pre-emptive therapy after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia;International Journal of Hematology;2024-05-25

5. Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies;Bone Marrow Transplantation;2024-05-23